Literature DB >> 7062945

Tamoxifen for lymphangioleiomyomatosis.

A Tomasian, M S Greenberg, H Rumerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7062945     DOI： 10.1056/NEJM198203253061215

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Lymphangiomyomatosis: a respiratory illness with an endocrinologic therapy.

Authors:  H O Sieker; K S McCarty
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

2.  Pulmonary tuberous sclerosis treated with tamoxifen and progesterone.

Authors:  C J Westermann; A C Oostveen; S S Wagenaar; C Hilvering; S E Overbeek; D Verheijen-Breemhaar; B Corrin
Journal:  Thorax       Date:  1986-11       Impact factor: 9.139

Review 3.  Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.

Authors:  Stephen C Juvet; Francis X McCormack; David J Kwiatkowski; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-10       Impact factor: 6.914

4.  Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

Authors:  Francis X McCormack; Nishant Gupta; Geraldine R Finlay; Lisa R Young; Angelo M Taveira-DaSilva; Connie G Glasgow; Wendy K Steagall; Simon R Johnson; Steven A Sahn; Jay H Ryu; Charlie Strange; Kuniaki Seyama; Eugene J Sullivan; Robert M Kotloff; Gregory P Downey; Jeffrey T Chapman; MeiLan K Han; Jeanine M D'Armiento; Yoshikazu Inoue; Elizabeth P Henske; John J Bissler; Thomas V Colby; Brent W Kinder; Kathryn A Wikenheiser-Brokamp; Kevin K Brown; Jean F Cordier; Cristopher Meyer; Vincent Cottin; Jan L Brozek; Karen Smith; Kevin C Wilson; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

5.  Tuberous sclerosis with pulmonary involvement.

Authors:  B A Liberman; D W Chamberlain; R S Goldstein
Journal:  Can Med Assoc J       Date:  1984-02-01       Impact factor: 8.262

6.  Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study.

Authors:  I Wahedna; S Cooper; J Williams; I C Paterson; J R Britton; A E Tattersfield
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

7.  Lymphangiomyomatosis: a report of three cases treated with tamoxifen.

Authors:  C Clemm; U Jehn; B Wolf-Hornung; G Siemon; G Walter
Journal:  Klin Wochenschr       Date:  1987-04-15

8.  Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience.

Authors:  Eva Revilla-López; Cristina Berastegui; Alejandra Méndez; Berta Sáez-Giménez; Victoria Ruiz de Miguel; Manuel López-Meseguer; Victor Monforte; Carlos Bravo; Miguel Angel Pujana; Maria Antonia Ramon; Susana Gómez-Ollés; Antonio Roman
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

9.  Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis.

Authors:  Paola Contini; Mario Schiavina; Riccardo Schiavina; Francesco Tavalazzi; Andrea Fabiani; Valerio Di Scioscio; Paolo Spagnolo; Luca Richeldi
Journal:  Multidiscip Respir Med       Date:  2011-10-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.